Update on multiple sclerosis therapy

Med Clin North Am. 1993 Jan;77(1):231-49. doi: 10.1016/s0025-7125(16)30281-4.

Abstract

Multiple sclerosis is a demyelinating disorder of the central nervous system characterized by exacerbations and remissions of symptoms. This article deals with symptomatic therapy involving treatment of spasticity, fatigue, neurobehavioral disorders, paroxysmal disorders, pain, bladder dysfunction, and cerebellar dysfunction. This article also reviews immunosuppressive therapies including treatment of acute exacerbations or overall progression of the disorder with resultant accumulation of disability.

Publication types

  • Review

MeSH terms

  • Amantadine / therapeutic use
  • Baclofen / therapeutic use
  • Fatigue / drug therapy
  • Fatigue / etiology
  • Humans
  • Immunosuppression Therapy
  • Interferons / therapeutic use
  • Multiple Sclerosis / physiopathology
  • Multiple Sclerosis / rehabilitation
  • Multiple Sclerosis / therapy*
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / etiology

Substances

  • Interferons
  • Amantadine
  • Baclofen